Polyrizon Ltd. Ordinary Shares - Asset Resilience Ratio

Latest as of December 2024: 0.00%

Polyrizon Ltd. Ordinary Shares (PLRZ) has an Asset Resilience Ratio of 0.00% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PLRZ working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$0.00
Cash + Short-term Investments

Total Assets

$5.55 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2024–2024)

This chart shows how Polyrizon Ltd. Ordinary Shares's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see PLRZ total assets.

Liquid Assets Composition Over Time

This chart breaks down Polyrizon Ltd. Ordinary Shares's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Polyrizon Ltd. Ordinary Shares debt and liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $0.00 0%
Total Liquid Assets $0.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: Polyrizon Ltd. Ordinary Shares maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

Polyrizon Ltd. Ordinary Shares Industry Peers by Asset Resilience Ratio

Compare Polyrizon Ltd. Ordinary Shares's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
ALK-Abelló A/S
CO:ALK-B
Biotechnology 0.98%
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Biotechnology 6.89%
Xiamen Amoytop Biotech Co Ltd
SHG:688278
Biotechnology 4.69%
BB Biotech AG
SW:BION
Biotechnology 92.97%
Soleno Therapeutics Inc
NASDAQ:SLNO
Biotechnology 20.15%
Nanobiotix
NASDAQ:NBTX
Biotechnology 4.71%
Wuhan Keqian Biology Co Ltd
SHG:688526
Biotechnology 19.42%
Beijing Konruns Pharmaceutical Co Ltd
SHG:603590
Biotechnology 10.55%

Annual Asset Resilience Ratio for Polyrizon Ltd. Ordinary Shares (2024–2024)

The table below shows the annual Asset Resilience Ratio data for Polyrizon Ltd. Ordinary Shares.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.00% $0.00 $5.55 Million --
pp = percentage points

About Polyrizon Ltd. Ordinary Shares

NASDAQ:PLRZ USA Biotechnology
Market Cap
$11.49 Million
Market Cap Rank
#26791 Global
#5565 in USA
Share Price
$11.03
Change (1 day)
+3.57%
52-Week Range
$0.52 - $17.17
All Time High
$17.17
About

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nas… Read more